Aetion

📍 New York, United States🗓 Founded 2012👥 310 employees💰 Last funded May 2021
Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.
8
Total investors
0
Early stage
2
Mid stage
6
Late stage
2012
Founded
Investor geography2 countries
United States
7
United Kingdom
1
Investor activity2016–2021 · investors recorded per year
2016120171201912020120214
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aetion?
Aetion has 8 investors on record on gritt.io, 2 mid-stage and 6 late-stage investors.
When did Aetion last raise funding?
The most recent investment in Aetion recorded on gritt.io was in May 2021.
When was Aetion founded?
Aetion was founded in 2012.
What industry is Aetion in?
Aetion operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Aetion based?
Aetion is headquartered in New York, United States.